Briefly, under the circumstance of hypoxic microenvironment within tumors, METTL3 depletion has been discovered to substantially contribute to the acquired sorafenib resistance in HCC via FOXO3-mediated autophagy. The gene discussed is METTL3; the disease is hepatocellular carcinoma.